Financing Through Stock Acquisition Rights with a Variable Exercise Price
First written in FY2017. 21 of 23 entries say "Advanced", first in FY2018-Q1. Latest entry: FY2026.
20 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「1 April 2025–31 March 2026 (Note 1) 23,600 23,118,900 4 2,222 4 2,366 (Note 1) Increase resulting from the exercise of stock acquisition rights.」
During the consolidated fiscal year, exercise of stock acquisition rights resulted in the issuance of 23,600 shares, increasing stated capital and capital surplus by ¥4 million each. - FY2026-H1AdvancedAnnual report
「1 April 2025–30 September 2025 (Note) 23,600 23,118,900 4 2,222 4 2,366 (Note) Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights resulted in the issuance of 23,600 shares, increasing stated capital and capital surplus by ¥4 million each. Financing and the increase in capital through exercise continued. - FY2025AdvancedAnnual report
「1 April 2024–31 March 2025 (Note 1) 95,600 23,095,300 19 2,217 19 2,361 (Note 1) Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights progressed, resulting in the issuance of 95,600 shares during the consolidated fiscal year and increasing stated capital and capital surplus by ¥19 million each. - FY2025-H1AdvancedAnnual report
「1 April 2024–30 September 2024 (Note 1) 20,000 23,019,700 3 2,202 3 2,346 (Note 1) Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights resulted in the issuance of 20,000 shares during the six-month interim consolidated accounting period, increasing stated capital and capital surplus by ¥3 million each. - FY2024AdvancedAnnual report
「1 April 2023–31 March 2024 (Notes 1 and 2) 55,600 22,999,700 11 2,198 △17 2,342 (Note 1) Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights with exercise price adjustment provisions and other rights progressed, resulting in the issuance of 55,600 shares and an ¥11 million increase in stated capital during the year. - FY2024-Q3AdvancedAnnual report
「1 October 2023–31 December 2023 (Note 1) 4,000 22,948,100 0 2,187 0 2,332 (Note 1) Increase due to the exercise of stock acquisition rights.」
During the third quarter, exercise of stock acquisition rights resulted in the issuance of 4,000 shares, and capital raising and the increase in capital continued. The issuance of a further 5,600 shares in January 2024 before the filing date was also disclosed. - FY2023-Q3AdvancedAnnual report
「1 October 2022–31 December 2022 (Note 1) 3,600 22,883,700 0 2,175 0 2,348 (Note 1) Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights continued, with 3,600 shares issued during the third quarter. The issuance of a further 48,400 shares by the filing date was also disclosed. - FY2023-Q2AdvancedAnnual report
「1 July 2022–30 September 2022 (Note) 12,400 22,880,100 5 2,174 5 2,347 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter, exercise of stock acquisition rights resulted in the issuance of 12,400 shares, increasing stated capital and capital surplus by ¥5 million each. - FY2023-Q1AdvancedAnnual report
「1 April 2022–30 June 2022 (Note) 15,500 22,867,700 5 2,169 5 2,342 (Note) Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights resulted in the issuance of 15,500 shares, increasing stated capital and capital surplus by ¥5 million each. - FY2022-Q3AdvancedAnnual report
「1 October 2021–31 December 2021 (Note) 14,000 22,651,000 2 2,114 2 2,288 (Note) Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights resulted in the issuance of 14,000 shares, increasing stated capital and capital surplus by ¥2 million each. - FY2022-Q2AdvancedAnnual report
「1 July 2021–30 September 2021 (Note 1) 44,500 22,637,000 12 2,111 12 2,285 (Note 1) Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights resulted in the issuance of 44,500 shares, increasing stated capital and capital surplus by ¥12 million each. - FY2022-Q1AdvancedAnnual report
「(Note 1) Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights resulted in the issuance of 38,000 shares from April to June 2021, increasing stated capital and capital surplus by ¥9 million each. A further 17,000 shares were issued by the filing date. - FY2021AdvancedAnnual report
「During the consolidated fiscal year, 233,100 shares were exercised」
Exercise of stock acquisition rights with exercise price adjustment provisions and other rights continued. In FY2021, 233,100 shares were issued, increasing stated capital and capital surplus by ¥56 million each. - FY2021-Q3AdvancedAnnual report
「1 October 2020–31 December 2020 (Note 1) 193,700 22,515,100 48 2,081 48 2,254 (Note 1) Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights progressed. A total of 193,700 shares were issued during the third quarter, increasing stated capital and capital surplus by ¥48 million each. - FY2020-Q3AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Exercise of stock acquisition rights with exercise price adjustment provisions and other rights continued. A total of 48,600 shares were issued from October through December 2019, increasing stated capital and capital surplus by ¥10 million each. - FY2020-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Exercise of stock acquisition rights with exercise price adjustment provisions and other rights continued. From April to June 2019, 12,800 shares were issued, increasing stated capital and capital surplus by ¥2 million each. - FY2019-Q3AdvancedAnnual report
「1 October 2018–31 December 2018: 44,400 shares / Increase due to the exercise of stock acquisition rights.」
Exercise of stock acquisition rights with exercise price adjustment provisions and other rights continued. A further 44,400 shares were issued during the third quarter, increasing stated capital and capital surplus by ¥8 million each. - FY2019-Q2AdvancedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights: ¥12 million」
Financing through the exercise of stock acquisition rights continued during the second quarter. - FY2018ReframedAnnual report
「Under these circumstances, the company changed the use of the unused funds raised, within the scope of the original purpose of issuing these stock acquisition rights, primarily to fund additional acquisitions of shares in domestic and overseas subsidiaries that became consolidated subsidiaries through past M&A, with the aim of strengthening governance over those subsidiaries and increasing their contribution to the Group's consolidated results.」
The amount raised through the stock acquisition rights was ¥3,269 million, and net proceeds were ¥3,252 million. The company made a ¥198 million investment in an HRTech fund and repaid ¥1,568 million in interest-bearing debt. The use of the remaining unused balance of ¥1,486 million was changed to additional acquisitions of shares in existing consolidated subsidiaries and other purposes. - FY2018-Q3AdvancedAnnual report
「During the current nine-month consolidated accounting period, the Company issued new shares and disposed of treasury shares through the exercise of stock acquisition rights, increasing share capital by ¥1,369 million and capital surplus by ¥1,628 million, while treasury shares decreased by ¥314 million.」
Capital raising and the resulting increase in capital through the exercise of stock acquisition rights continued. During the third quarter, the exercise of stock acquisition rights increased the number of shares by 124,600, while stated capital and capital surplus each increased by ¥54 million. - FY2018-Q2AdvancedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights amounted to ¥2,606 million」
Exercise of stock acquisition rights with exercise price adjustment provisions and other rights progressed, raising ¥2,606 million during the six-month period ended the second quarter. The financing progressed beyond the partial implementation stage. - FY2018-Q1AdvancedAnnual report
「Some of the fifth series of stock acquisition rights were exercised between 1 July 2017 and 4 August 2017. An overview of the exercise is provided below.」
A total of 7,397 Series 5 stock acquisition rights with exercise price adjustment provisions were exercised, raising ¥648 million. A total of 8,669 unexercised rights remained, and the financing had progressed to partial implementation. - FY2017First statedAnnual report
「The total number of common shares underlying these stock acquisition rights is fixed at 3,600,000, and the number of common shares underlying each stock acquisition right is fixed at 100, and」
For the stock acquisition rights with exercise price adjustment provisions issued in March 2017, the company set a VWAP-linked exercise price, a minimum exercise price of ¥359, a minimum funding amount of approximately ¥1.3 billion, and a facility agreement, among other terms.